Spain is gaining influence in European medical research thanks to the boom in clinical trials

For years, when people spoke of biomedical research in Europe, attention tended to focus on countries such as Germany, the United Kingdom or France. However, over the last decade, the landscape has changed more than might appear at first glance. Spain has gone from holding a prominent position to becoming one of the countries with the highest level of clinical trial activity on the continent.

Clinical research is the crucial step before a new medicine reaches patients. After years of laboratory work, treatments must be evaluated in human trials to verify that they are effective and safe. These trials require hospitals with research expertise, trained medical teams and regulatory systems capable of rigorously overseeing the process.

In that context, Spain has been consolidating a environment particularly favourable for this type of research. Public hospitals, many of which are university hospitals, participate today in a regular basis in international research networks. In these projects collaborate doctors, scientists, institutions academic and pharmaceutical companies from various countries.

The results are reflected in the figures. Every year, hundreds of clinical trials involving medicines are authorised in Spain, many of which relate to innovative therapies that are still at an advanced stage of development.

A significant proportion of these studies focus on oncology. This is hardly surprising: cancer treatment is one of the areas where medical innovation is advancing most rapidly. Targeted therapies, immunotherapy and personalised treatments are transforming the way the disease is treated, and many of these advances are currently being trialled in Spanish hospitals.

However, clinical research is not limited to just cancer. There is also a growing number of studies on rare diseases, neurology, immunology or cardiovascular conditions. In many cases, these are part of international projects in which various medical centres participate medical centres from various countries at the same time.

For healthcare professionals, these studies offer an opportunity to work at the forefront of biomedical research. For patients, in some cases, they provide access to treatments that are not yet available in standard clinical practice.

According to Amelia Martín Uranga, Director of Clinical and Translational Research at Farmaindustria, this position is the result of a collaborative model that has been developed over many years.

“Spain has become a global leader in clinical trials thanks to the commitment of all those involved: researchers, hospitals, the pharmaceutical industry, regulators and patients,” he notes.

This leadership also has wider-reaching effects. Clinical research attracts investment in biomedicine, drives innovation in hospitals and strengthens the country’s scientific ecosystem. At a time when the development of new therapies is becoming increasingly complex and costly, having a robust network of centres capable of participating in these studies has become a strategic asset.

Beyond the figures, the growth in clinical trials reflects something more profound: Spain’s integration into the major international networks that are driving the medicine of the future.

Frequently Asked Questions FAQ

What is a clinical trial?
It is a scientific study in which new medicines or treatments are tested on patients to assess their efficacy and safety.

Who can take part in a clinical trial?
People who meet certain medical criteria defined by the researchers and who agree to take part on a voluntary basis.

What role do hospitals play in these studies?
Hospitals recruit patients, administer the treatments being studied and record the study results.

Which medical fields attract the most clinical research?
Primarily oncology, rare diseases, neurology and immunology.

Are there benefits for patients in taking part in a clinical trial?
En algunos casos permite acceder a terapias innovadoras antes de que estén disponibles de forma general.

Sources

https://www.aemps.gob.es/informa/espana-consolida-su-liderazgo-europeo-en-investigacion-clinica/

https://www.farmaindustria.es/web/otra-noticia/espana-vuelve-a-liderar-los-ensayos-clinicos-en-europa-pero-afronta-el-reto-de-competir-en-la-carrera-biomedica-global/

https://clinicaltrials.gov